Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Current Leases (2019 - 2022)

Historic Current Leases for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Q3 2022 value amounting to $1.0 million.

  • Avadel Pharmaceuticals' Current Leases rose 10059.52% to $1.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.0 million, marking a year-over-year increase of 10059.52%. This contributed to the annual value of $900000.0 for FY2021, which is 8987.34% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Current Leases stood at $1.0 million for Q3 2022, which was up 10059.52% from $932000.0 recorded in Q2 2022.
  • In the past 5 years, Avadel Pharmaceuticals' Current Leases ranged from a high of $1.6 million in Q3 2019 and a low of $474000.0 during Q4 2020
  • Over the past 4 years, Avadel Pharmaceuticals' median Current Leases value was $645000.0 (recorded in 2019), while the average stood at $775000.0.
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 6741.85% in 2020, then surged by 10059.52% in 2022.
  • Avadel Pharmaceuticals' Current Leases (Quarter) stood at $645000.0 in 2019, then dropped by 26.51% to $474000.0 in 2020, then soared by 89.87% to $900000.0 in 2021, then grew by 12.33% to $1.0 million in 2022.
  • Its last three reported values are $1.0 million in Q3 2022, $932000.0 for Q2 2022, and $917000.0 during Q1 2022.